Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells

BACKGROUND: Hepatocellular carcinoma (HCC) represents a serious public health problem worldwide and has high morbidity and mortality. Dihydromyricetin (DHM) exhibits anticancer effect on a variety of malignancies, but its anticancer function of DHM in HCC has been unclear. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lianggui, Ye, Wen-Chu, Li, Zuobiao, Yang, Yongguang, Dai, Wei, Li, Mingyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258952/
https://www.ncbi.nlm.nih.gov/pubmed/34229692
http://dx.doi.org/10.1186/s12906-021-03356-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258952/
https://www.ncbi.nlm.nih.gov/pubmed/34229692
http://dx.doi.org/10.1186/s12906-021-03356-5

Ejemplares similares